Entropy Technologies LP Has $265,000 Stock Position in Morningstar, Inc. $MORN

Entropy Technologies LP lowered its stake in shares of Morningstar, Inc. (NASDAQ:MORN) by 64.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,565 shares of the business services provider’s stock after selling 2,870 shares during the quarter. Entropy Technologies LP’s holdings in Morningstar were worth $265,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Morningstar by 23.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 178 shares of the business services provider’s stock worth $53,000 after purchasing an additional 34 shares during the last quarter. Focus Partners Wealth raised its position in shares of Morningstar by 3.4% during the first quarter. Focus Partners Wealth now owns 3,838 shares of the business services provider’s stock valued at $1,151,000 after buying an additional 126 shares during the last quarter. Geneos Wealth Management Inc. raised its position in shares of Morningstar by 278.2% during the first quarter. Geneos Wealth Management Inc. now owns 208 shares of the business services provider’s stock valued at $62,000 after buying an additional 153 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in shares of Morningstar by 2,450.0% in the second quarter. EverSource Wealth Advisors LLC now owns 561 shares of the business services provider’s stock valued at $176,000 after buying an additional 539 shares during the period. Finally, Qube Research & Technologies Ltd lifted its stake in shares of Morningstar by 58.8% in the second quarter. Qube Research & Technologies Ltd now owns 138,932 shares of the business services provider’s stock valued at $43,615,000 after buying an additional 51,449 shares during the period. 57.02% of the stock is currently owned by institutional investors and hedge funds.

Morningstar Price Performance

NASDAQ:MORN opened at $192.57 on Friday. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.03 and a current ratio of 1.06. The company has a 50-day moving average of $172.26 and a 200-day moving average of $177.34. Morningstar, Inc. has a 52 week low of $141.49 and a 52 week high of $279.33. The company has a market capitalization of $7.22 billion, a price-to-earnings ratio of 18.24 and a beta of 1.01.

Morningstar (NASDAQ:MORN) last posted its earnings results on Wednesday, July 29th. The business services provider reported $3.10 earnings per share for the quarter, beating analysts’ consensus estimates of $2.83 by $0.27. Morningstar had a net margin of 16.43% and a return on equity of 38.57%. The business had revenue of $663.20 million for the quarter, compared to analysts’ expectations of $649.72 million.

Insider Buying and Selling at Morningstar

In other news, Chairman Joseph D. Mansueto sold 2,270 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $176.72, for a total value of $401,154.40. Following the sale, the chairman directly owned 8,043,492 shares in the company, valued at approximately $1,421,445,906.24. This represents a 0.03% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Holt sold 270 shares of the company’s stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $166.05, for a total value of $44,833.50. Following the completion of the sale, the chief financial officer owned 12,326 shares in the company, valued at approximately $2,046,732.30. This represents a 2.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 57,470 shares of company stock valued at $9,929,576. 38.80% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. UBS Group lowered their price target on Morningstar from $280.00 to $260.00 and set a “buy” rating on the stock in a research note on Tuesday, July 7th. BMO Capital Markets reaffirmed an “outperform” rating and issued a $212.00 price target on shares of Morningstar in a report on Friday, June 26th. Wall Street Zen upgraded Morningstar from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Rothschild & Co Redburn set a $210.00 price objective on Morningstar in a report on Thursday, June 18th. Finally, Weiss Ratings cut Morningstar from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Morningstar currently has a consensus rating of “Hold” and a consensus price target of $227.33.

Morningstar Company Profile

Morningstar, Inc is a leading provider of independent investment research, data, and analytics, serving both individual investors and financial professionals. The company offers comprehensive coverage of financial products, including mutual funds, exchange-traded funds (ETFs), stocks, bonds and market indexes. Morningstar’s proprietary rating systems and research methodologies help clients assess the risk and return profiles of investment opportunities and make informed decisions.

Its core products include Morningstar Direct, an institutional investment analysis platform; Morningstar Office Cloud, a portfolio management solution for advisors; and Morningstar Data, which delivers extensive datasets through APIs and data feeds.